Document Type : Original Article


Department of Pharmaceutics, Smt. Sarojini Ramulamma College of Pharmacy, Palamuru University, Seshadri Nagar, Mahabubnagar District, Telangana State, India


The occurrence of an ischemic stroke arises from the unfortunate circumstance in which a blood vessel becomes impeded or obstructed, resulting from the presence of a clot, atherosclerosis, or the narrowing of arteries. The neurology department of a 300-bed, multi-specialty tertiary teaching hospital was the site of this six-month observational study. Prescriptions for both inpatients and outpatients in the neurology unit, totalling 90, are considered according to the inclusion criteria. Patient case sheets, questionnaires, interviews, biomedical and radiological reports, and drug regimen charts are the main data sources. Acute ischemic stroke (AIS) patients are more prevalent in the over-60 age group than in the 20–35 age group. The information obtained indicates that male patients have greater effects than female ones. Furthermore, our research indicates that AIS is more common in obese and overweight people. One of the main risk factors for developing AIS is alcohol drinking, tobacco chewing, and smoking, which affect most AIS patients. Treatment options for acute ischemic stroke (AIS) include intravenous thrombolytic therapy (IVT), anti-platelet therapy, anticoagulant therapy, and adjuvant therapies using statins and drugs based on the comorbidities of the patients. This research highlights that individuals with AIS have shown higher progress when physical rehabilitation is combined with intravenous thrombolytic treatment (IVT) for patients with comorbidities. We found that the individuals who continued taking their medicine and therapy after their discharge from the hospital had better motor strength than those who stopped. Our study concludes that the integration of pharmacotherapy with physical rehabilitation yielded significant enhancements in the functional capacity of individuals affected by stroke.

Graphical Abstract

An outlook study on the combination of pharmacotherapy and physical rehabilitation for clinically significant acute ischemic stroke patients


Main Subjects

Selected author of this article by journal

Dr. poluri koteswari
Smt Sarojini Ramulamma College of Pharmacy

Open Access

This article is licensed under a CC BY License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit:


Publisher’s Note

CMBR journal remains neutral with regard to jurisdictional claims in published maps and institutional afflictions.


Letters to Editor

Given that CMBR Journal's policy in accepting articles will be strict and will do its best to ensure that in addition to having the highest quality published articles, the published articles should have the least similarity (maximum 15%). Also, all the figures and tables in the article must be original and the copyright permission of images must be prepared by authors. However, some articles may have flaws and have passed the journal filter, which dear authors may find fault with. Therefore, the editor of the journal asks the authors, if they see an error in the published articles of the journal, to email the article information along with the documents to the journal office.

CMBR Journal welcomes letters to the editor ([email protected], [email protected]) for the post-publication discussions and corrections which allows debate post publication on its site, through the Letters to Editor. Critical letters can be sent to the journal editor as soon as the article is online. Following points are to be considering before sending the letters (comments) to the editor.

[1] Letters that include statements of statistics, facts, research, or theories should include appropriate references, although more than three are discouraged.

[2] Letters that are personal attacks on an author rather than thoughtful criticism of the author’s ideas will not be considered for publication.

[3] There is no limit to the number of words in a letter.

[4] Letter writers should include a statement at the beginning of the letter stating that it is being submitted either for publication or not.

[5] Anonymous letters will not be considered.

[6] Letter writers must include Name, Email Address, Affiliation, mobile phone number, and Comments.

[7] Letters will be answered as soon as possible.

  1. Simonsen SA, West AS, Heiberg AV, Wolfram F, Jennum PJ, Iversen HK (2022) Is the TOAST classification suitable for use in personalized medicine in ischemic stroke? Journal of Personalized Medicine 12 (3): 496. doi:
  2. Montaño A, Hanley DF, Hemphill JC (2021) Chapter 13 - Hemorrhagic stroke. In: Hetts SW, Cooke DL (eds) Handbook of Clinical Neurology, vol 176. Elsevier, pp 229-248. doi:
  3. Ntaios G (2020) Embolic stroke of undetermined source: JACC review topic of the week. Journal of the American College of Cardiology 75 (3): 333-340. doi:
  4. Yamunadevi A, Sulaja S (2016) Old Age Mortality in India–An Exploration from Life Expectancy at Age 60. International Journal of Asian Social Science 6 (12): 698-704. doi:
  5. Chobe M, Chobe S, Dayama S, Singh A, Metri K, Basa JR, Raghuram N, Singh Sr A, Raghuram N (2022) Prevalence of Non-Communicable Diseases and Its Associated Factors Among Urban Elderly of Six Indian States. Cureus 14 (10): e30123. doi:
  6. Jones SP, Baqai K, Clegg A, Georgiou R, Harris C, Holland E-J, Kalkonde Y, Lightbody CE, Maulik PK, Srivastava PM (2022) Stroke in India: A systematic review of the incidence, prevalence, and case fatality. International Journal of Stroke 17 (2): 132-140. doi:
  7. Campbell BC, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM, Donnan GA (2019) Ischaemic stroke. Nature reviews Disease primers 5 (1): 70. doi:
  8. Berkhemer OA, Fransen PS, Beumer D, Van Den Berg LA, Lingsma HF, Yoo AJ, Schonewille WJ, Vos JA, Nederkoorn PJ, Wermer MJ (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine 372 (1): 11-20. doi:
  9. Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, McTaggart RA, Torbey MT, Kim-Tenser M, Leslie-Mazwi T (2018) Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine 378 (8): 708-718. doi:
  10. Lisabeth LD, Brown DL, Hughes R, Majersik JJ, Morgenstern LB (2009) Acute stroke symptoms: comparing women and men. Stroke 40 (6): 2031-2036. doi:
  11. Turc G, Maïer B, Naggara O, Seners P, Isabel C, Tisserand M, Raynouard I, Edjlali M, Calvet D, Baron J-C (2016) Clinical scales do not reliably identify acute ischemic stroke patients with large-artery occlusion. Stroke 47 (6): 1466-1472. doi:
  12. Yousufuddin M, Young N (2019) Aging and ischemic stroke. Aging (Albany NY) 11 (9): 2542. doi:
  13. Rexrode KM, Madsen TE, Yu AY, Carcel C, Lichtman JH, Miller EC (2022) The impact of sex and gender on stroke. Circulation research 130 (4): 512-528. doi:
  14. Horn JW, Feng T, Mørkedal B, Strand LB, Horn J, Mukamal K, Janszky I (2021) Obesity and risk for first ischemic stroke depends on metabolic syndrome: the HUNT study. Stroke 52 (11): 3555-3561. doi:
  15. She R, Yan Z, Hao Y, Zhang Z, Du Y, Liang Y, Vetrano DL, Dekker J, Bai B, Lau JT (2022) Comorbidity in patients with first-ever ischemic stroke: Disease patterns and their associations with cognitive and physical function. Frontiers in Aging Neuroscience 14: 887032. doi:
  16. Goyal M, Ospel J (2020) Challenges to stroke care 5 years after endovascular therapy became the standard. The Lancet Neurology 19 (3): 210-211. doi:
  17. Aiyagari V, Gorelick PB (2009) Management of blood pressure for acute and recurrent stroke. Stroke 40 (6): 2251-2256. doi:
  18. Kersten C, Knottnerus I, Heijmans E, Haalboom M, Zandbergen A, den Hertog H (2022) Effect of metformin on outcome after acute ischemic stroke in patients with type 2 diabetes mellitus. Journal of Stroke and Cerebrovascular Diseases 31 (9): 106648. doi:
  19. Sandercock PA, Counsell C, Tseng MC, Cecconi E (2014) Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews(3). doi:
  20. Paciaroni M, Agnelli G, Falocci N, Tsivgoulis G, Vadikolias K, Liantinioti C, Chondrogianni M, Bovi P, Carletti M, Cappellari M (2017) Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non–Vitamin‐K Oral Anticoagulants (RAF‐NOAC s) Study. Journal of the American Heart Association 6 (12): e007034. doi:
  21. Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. New England Journal of Medicine 379 (3): 215-225. doi:
  22. Langhorne P, Wu O, Rodgers H, Ashburn A, Bernhardt J (2017) A Very Early Rehabilitation Trial after stroke (AVERT): a Phase III, multicentre, randomised controlled trial. Health Technology Assessment 21 (54): 1-119. doi: